VACCINE TECHNOLOGY

DIE VISION

TOO SLOW FOR THE UNIFIED VACCINE PLATFORM? Rapidly changing pathogens require an equally rapid vaccine platform. The aim is to match medical needs and precisely tailored vaccines. The Unified Vaccine Platform offers just that for animal health!
VEROVACCiNES novel vaccines are based on recombinant strains of the yeast Kluyveromyces lactis, which stably express one or more antigens.
This novel class of vaccines has significant advantages over conventional animal vaccines.

DAS TEAM

 

 

Dr. Hanjo Hennemann, Gründer

Dr. Hanjo Hennemann, Gründer

Prof. Dr. Sven-Ehrik Behrens, Gründer

Prof. Dr. Sven-Ehrik Behrens, Gründer

LUST AUF MEHR STORYS?